Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Emergent BioSolutions Inc. Common Stock
(NY:
EBS
)
4.830
-0.340 (-6.58%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Emergent BioSolutions Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts
May 02, 2024
Emergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results
May 02, 2024
Via
Benzinga
Why Is Freshworks (FRSH) Stock Down 17% Today?
May 02, 2024
Freshworks stock is falling on Thursday as FRSH investors learn of its CEO stepping down and react to lackluster 2024 guidance.
Via
InvestorPlace
Why Is Fastly (FSLY) Stock Down 36% Today?
May 02, 2024
Fastly stock is falling on Thursday as FSLY investors react to weak guidance and mixed results in its earnings report for Q1 2024.
Via
InvestorPlace
Why Is Carvana (CVNA) Stock Up 36% Today?
May 02, 2024
Carvana stock is up on Thursday after the company surprised CVNA investors with record profits and revenue during the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 02, 2024
Via
Benzinga
Emergent BioSolutions: Q4 Earnings Insights
March 06, 2024
Via
Benzinga
Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?
May 02, 2024
Emergent BioSolutions stock is up on Thursday after the life sciences company posted a surprising profit and strong earnings in Q1 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 02, 2024
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
Via
InvestorPlace
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 02, 2024
Via
Benzinga
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
May 01, 2024
EBS earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
EBS stock results show that Emergent BioSolutions beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Emergent BioSolutions Reports First Quarter 2024 Financial Results
May 01, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
May 01, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
May 01, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 01, 2024
Via
Benzinga
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
April 30, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
April 22, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
April 01, 2024
Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
March 28, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
March 25, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 07, 2024
Via
Benzinga
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via
Benzinga
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
March 07, 2024
Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued strong revenue...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 07, 2024
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!
Via
InvestorPlace
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
March 06, 2024
EBS earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023
March 06, 2024
EBS stock results show that Emergent BioSolutions missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement
March 06, 2024
Emergent BioSolutions reported quarterly losses of 77 cents per share, missing the analyst consensus estimate of losses of 19 cents per share. Quarterly sales came in at $276.6 million which missed the...
Via
Benzinga
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
March 06, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Earnings Scheduled For March 6, 2024
March 06, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.